Report Detail

Pharma & Healthcare Global Remifentanil Hydrochloride Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2995950
  • |
  • 21 February, 2019
  • |
  • Global
  • |
  • 121 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.

Scope of the Report:
Remifentanil Hydrochloride is a kind of high-end opioid analgesic, it can used in the maintain analgesia and anesthesia induction of general anesthesia, it has the feature of working fast, no accumulate in the body, blood and drug concentration smooth, short duration of action, strong analgesic potency, recover quickly after using, light adverse reactions and so on.

The global remifentanil hydrochloride company mainly concentrates in the developed countries, the consumption groups also concentrate in the developed countries and the high income people.

The Europe remifentanil hydrochloride industry is mainly concentrated in the UK and Germany, it has a high degree of industrial concentration, it is mainly due to the patent and the technology monopoly, the UK and Germany has the highest production and consumption, the consumption groups are mainly higher income levels due to the high price.

The remifentanil hydrochloride is produced in the developed countries, so the import and export are between developing countries and developed countries. The remifentanil hydrochloride has relative high growth rate and the gross margin is about 80%.

The worldwide market for Remifentanil Hydrochloride is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Remifentanil Hydrochloride in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
1mg/Pcs
2mg/Pcs
5mg/Pcs

Market Segment by Applications, can be divided into
Endotracheal intubation operation
Neurosurgery
Outpatient surgery
Postoperative analgesia
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Remifentanil Hydrochloride product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Remifentanil Hydrochloride, with price, sales, revenue and global market share of Remifentanil Hydrochloride in 2017 and 2018.
Chapter 3, the Remifentanil Hydrochloride competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Remifentanil Hydrochloride breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Remifentanil Hydrochloride market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Remifentanil Hydrochloride sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Remifentanil Hydrochloride Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 1mg/Pcs
      • 1.2.2 2mg/Pcs
      • 1.2.3 5mg/Pcs
    • 1.3 Market Analysis by Applications
      • 1.3.1 Endotracheal intubation operation
      • 1.3.2 Neurosurgery
      • 1.3.3 Outpatient surgery
      • 1.3.4 Postoperative analgesia
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GSK
      • 2.1.1 Business Overview
      • 2.1.2 Remifentanil Hydrochloride Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GSK Remifentanil Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Macfarlan Smith
      • 2.2.1 Business Overview
      • 2.2.2 Remifentanil Hydrochloride Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Macfarlan Smith Remifentanil Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Abbott
      • 2.3.1 Business Overview
      • 2.3.2 Remifentanil Hydrochloride Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Abbott Remifentanil Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Mylan
      • 2.4.1 Business Overview
      • 2.4.2 Remifentanil Hydrochloride Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Mylan Remifentanil Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Arevipharma
      • 2.5.1 Business Overview
      • 2.5.2 Remifentanil Hydrochloride Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Arevipharma Remifentanil Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 AMRI
      • 2.6.1 Business Overview
      • 2.6.2 Remifentanil Hydrochloride Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 AMRI Remifentanil Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Remifentanil Hydrochloride Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Remifentanil Hydrochloride Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Remifentanil Hydrochloride Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Remifentanil Hydrochloride Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Remifentanil Hydrochloride Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Remifentanil Hydrochloride Market Analysis by Regions

    • 4.1 Global Remifentanil Hydrochloride Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Remifentanil Hydrochloride Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Remifentanil Hydrochloride Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 4.3 Europe Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 4.5 South America Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)

    5 North America Remifentanil Hydrochloride by Country

    • 5.1 North America Remifentanil Hydrochloride Sales, Revenue and Market Share by Country
      • 5.1.1 North America Remifentanil Hydrochloride Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Remifentanil Hydrochloride Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 5.3 Canada Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)

    6 Europe Remifentanil Hydrochloride by Country

    • 6.1 Europe Remifentanil Hydrochloride Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Remifentanil Hydrochloride Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Remifentanil Hydrochloride Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 6.3 UK Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 6.4 France Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 6.5 Russia Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 6.6 Italy Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Remifentanil Hydrochloride by Country

    • 7.1 Asia-Pacific Remifentanil Hydrochloride Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Remifentanil Hydrochloride Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Remifentanil Hydrochloride Revenue and Market Share by Country (2014-2019)
    • 7.2 China Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 7.3 Japan Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 7.4 Korea Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 7.5 India Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)

    8 South America Remifentanil Hydrochloride by Country

    • 8.1 South America Remifentanil Hydrochloride Sales, Revenue and Market Share by Country
      • 8.1.1 South America Remifentanil Hydrochloride Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Remifentanil Hydrochloride Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Remifentanil Hydrochloride by Countries

    • 9.1 Middle East and Africa Remifentanil Hydrochloride Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Remifentanil Hydrochloride Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Remifentanil Hydrochloride Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Remifentanil Hydrochloride Sales and Growth Rate (2014-2019)

    10 Global Remifentanil Hydrochloride Market Segment by Type

    • 10.1 Global Remifentanil Hydrochloride Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Remifentanil Hydrochloride Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Remifentanil Hydrochloride Revenue and Market Share by Type (2014-2019)
    • 10.2 1mg/Pcs Sales Growth and Price
      • 10.2.1 Global 1mg/Pcs Sales Growth (2014-2019)
      • 10.2.2 Global 1mg/Pcs Price (2014-2019)
    • 10.3 2mg/Pcs Sales Growth and Price
      • 10.3.1 Global 2mg/Pcs Sales Growth (2014-2019)
      • 10.3.2 Global 2mg/Pcs Price (2014-2019)
    • 10.4 5mg/Pcs Sales Growth and Price
      • 10.4.1 Global 5mg/Pcs Sales Growth (2014-2019)
      • 10.4.2 Global 5mg/Pcs Price (2014-2019)

    11 Global Remifentanil Hydrochloride Market Segment by Application

    • 11.1 Global Remifentanil Hydrochloride Sales Market Share by Application (2014-2019)
    • 11.2 Endotracheal intubation operation Sales Growth (2014-2019)
    • 11.3 Neurosurgery Sales Growth (2014-2019)
    • 11.4 Outpatient surgery Sales Growth (2014-2019)
    • 11.5 Postoperative analgesia Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Remifentanil Hydrochloride Market Forecast (2019-2024)

    • 12.1 Global Remifentanil Hydrochloride Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Remifentanil Hydrochloride Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Remifentanil Hydrochloride Market Forecast (2019-2024)
      • 12.2.2 Europe Remifentanil Hydrochloride Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Remifentanil Hydrochloride Market Forecast (2019-2024)
      • 12.2.4 South America Remifentanil Hydrochloride Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Remifentanil Hydrochloride Market Forecast (2019-2024)
    • 12.3 Remifentanil Hydrochloride Market Forecast by Type (2019-2024)
      • 12.3.1 Global Remifentanil Hydrochloride Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Remifentanil Hydrochloride Market Share Forecast by Type (2019-2024)
    • 12.4 Remifentanil Hydrochloride Market Forecast by Application (2019-2024)
      • 12.4.1 Global Remifentanil Hydrochloride Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Remifentanil Hydrochloride Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Remifentanil Hydrochloride . Industry analysis & Market Report on Remifentanil Hydrochloride is a syndicated market report, published as Global Remifentanil Hydrochloride Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Remifentanil Hydrochloride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,738.76
      4,108.14
      5,477.52
      3,205.08
      4,807.62
      6,410.16
      543,158.40
      814,737.60
      1,086,316.80
      289,953.60
      434,930.40
      579,907.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report